• FirefoxInstall the new Firefox »
  •  Dow Down1.54% Nasdaq Down1.11%

    Biogen Idec Inc. (BIIB)

    -NasdaqGS
    417.63 Down 7.98(1.87%) Mar 6, 4:00PM EST
    |After Hours : 417.50 Down 0.13 (0.03%) Mar 6, 7:44PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 2,640,675   2,511,446   2,421,452   2,129,751  
    Cost of Revenue297,265  302,639  291,887  279,245  
    Gross Profit 2,343,410   2,208,807   2,129,565   1,850,506  
    Operating Expenses
    Research Development500,091  417,174  447,273  528,884  
    Selling General and Administrative580,930  521,003  580,641  510,875  
    Non Recurring -   -   -   -  
    Others107,246  122,431  116,826  143,258  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 1,159,763   1,152,578   988,725   671,348  
    Income from Continuing Operations
    Total Other Income/Expenses Net(4,131)(11,911)8,761  (1,742)
    Earnings Before Interest And Taxes1,155,632  1,140,667  997,486  669,606  
    Interest Expense -   -   -   -  
    Income Before Tax1,155,632  1,140,667  997,486  669,606  
    Income Tax Expense268,233  274,774  268,521  178,414  
    Minority Interest879  738  (8,626)228  
    Net Income From Continuing Ops888,084  861,237  718,406  483,815  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 883,464   856,858   714,506   479,956  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 883,464   856,858   714,506   479,956  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.